한국어 English Tiếng Việt

The K Company Wins Top Honors in Beauty Tech Investment Program

2026-05-21 · * 윤경선 koia7@jangup.com * 승인 2026.05.20 11:02 * 댓글 0

The K Company, led by CEO Kim Sung-woo, announced on the 14th that it emerged as the final winner of the 13th installment of the "Gongmyeongjeon" startup investment accelerator program. This competitive program, which ran for approximately one and a half months, evaluated beauty and AI-focused startups on their business viability, technological innovation, and market potential.

Concluding with an offline investor relations event hosted by Draper Startup House, the 13th Gongmyeongjeon attracted around 20 investors who participated in the selection process. The final winner was determined through an online voting mechanism, allowing approximately 100 investors to cast their votes.

The K Company operates a dual business model encompassing the clinical research institution, the K Dermatological Science Institute, and the automation solutions provider, The K Solution. By merging offline research with online SaaS technology, the company has developed a unique operational structure that enhances both efficiency and market reach.

Recognizing the inefficiencies inherent in the current manpower-driven cosmetics clinical testing and regulatory landscape, The K Company leverages AI-based automation technologies to streamline the report generation and regulatory processes. This strategic pivot not only reduces time and cost but also positions the company as a leader in operational efficiency.

The firm promotes a virtuous cycle of solution enhancement based on clinical data accumulation and research experience from the field. This approach directly addresses challenges encountered in research settings, subsequently utilizing IT solutions to resolve them, which enhances their competitive edge.

CEO Kim Sung-woo articulated that the victory at Gongmyeongjeon isn't merely an accolade; it validates the potential for technological innovation within the inefficiencies of the cosmetics sector. He emphasized ambitions to utilize the investment to further bolster their AI automation capabilities and global regulatory responsiveness, aiming to establish The K Company as a foundational player in the global beauty industry.

Looking ahead, The K Company plans to expand its business focus on automating efficacy reporting for cosmetics, developing systems for global regulatory compliance, and enhancing data-driven clinical analysis technologies.

← Back to list